Skip Nav Destination
Issues
June 2017
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 0028-3835
EISSN 1423-0194
In this Issue
Neuroendocrinology 2017, Vol. 105, No. 1
At the Cutting Edge
Effect of Gonadal Hormones on Neurotransmitters Implicated in the Pathophysiology of Obsessive-Compulsive Disorder: A Critical Review
Neuroendocrinology (2017) 105 (1): 1–16.
https://doi.org/10.1159/000453664
Original Paper
High Frequency of MKRN3 Mutations in Male Central Precocious Puberty Previously Classified as Idiopathic
Danielle S. Bessa; Delanie B. Macedo; Vinicius N. Brito; Monica M. França; Luciana R. Montenegro; Marina Cunha-Silva; Leticia G. Silveira; Tiago Hummel; Ignacio Bergadá; Debora Braslavsky; Ana Paula Abreu; Andrew Dauber; Berenice B. Mendonca; Ursula B. Kaiser; Ana Claudia Latronico
Neuroendocrinology (2017) 105 (1): 17–25.
https://doi.org/10.1159/000446963
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study
Amandine Berdelou; Valérie Boige; Julia Arfi-Rouche; David Malka; Stéphane Ederhy; Hassan Izzedine; Sophie Leboulleux; Cécile N. Chougnet; Pascal Burtin; Thierry De Baere; Agnès Laplanche; Dominique Elias; Martin Schlumberger; Jean-Yves Scoazec; Michel Ducreux; Eric Baudin
Neuroendocrinology (2017) 105 (1): 26–34.
https://doi.org/10.1159/000446988
Melatonin Receptor 1 Deficiency Affects Feeding Dynamics and Pro-Opiomelanocortin Expression in the Arcuate Nucleus and Pituitary of Mice
Claudia Fischer; Tanja Mueller; Martina Pfeffer; Helmut Wicht; Charlotte von Gall; Horst-Werner Korf
Neuroendocrinology (2017) 105 (1): 35–43.
https://doi.org/10.1159/000448333
Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant
Sanne E. Franck; Federico Gatto; Aart Jan van der Lely; Joseph A.M.J.L. Janssen; Alof H.G. Dallenga; A. Paul Nagtegaal; Leo J. Hofland; Sebastian J.C.M.M. Neggers
Neuroendocrinology (2017) 105 (1): 44–53.
https://doi.org/10.1159/000448429
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
Di Yu; Justyna Leja-Jarblad; Angelica Loskog; Per Hellman; Valeria Giandomenico; Kjell Oberg; Magnus Essand
Neuroendocrinology (2017) 105 (1): 54–66.
https://doi.org/10.1159/000448430
Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study)
Jean-Yves Scoazec; Anne Couvelard; Geneviève Monges; Serge Guyétant; Segolène Bisot-Locard; Xavier Parot; Côme Lepage; the PRONET Study Group
Neuroendocrinology (2017) 105 (1): 67–76.
https://doi.org/10.1159/000448431
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease
Helma Freitag; Friederike Christen; Florentine Lewens; Irina Grass; Franziska Briest; Sara Iwaszkiewicz; Britta Siegmund; Patricia Grabowski
Neuroendocrinology (2017) 105 (1): 90–104.
https://doi.org/10.1159/000448843